# Obese Patients With or Without Comorbidities (RIO-North America)

> **NCT00029861** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 3045 (actual)

## Conditions studied

- Obesity
- Weight Loss

## Interventions

- **DRUG:** Rimonabant (SR141716)

## Key facts

- **NCT ID:** NCT00029861
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** 2004-04
- **Final completion:** 2004-04
- **Target enrollment:** 3045 (ACTUAL)
- **Last updated:** 2009-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00029861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00029861, "Obese Patients With or Without Comorbidities (RIO-North America)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00029861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*